endocrinology
Hypercalcaemia Management
Diagnosis and treatment of hypercalcaemia — PTH-mediated vs malignancy
Source: NICE / Endocrine Society
Step 1 of ~8
info
Hypercalcaemia
Corrected Ca >2.6 mmol/L. Mild: 2.6–3.0. Moderate: 3.0–3.5. Severe: >3.5 or symptomatic (bones, stones, abdominal groans, psychic moans).
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Silicone Gel / Sheeting (Scar Management) · Medical Device / Topical Scar Treatment
- Insulin (IV Infusion — ICU Glucose Control) · Insulin — ICU Glucose Management
- Sodium Chloride 3% (Hypertonic Saline) · Hypertonic Electrolyte Solution — ICP/Hyponatraemia Management
- Thiamine (IV/IM — Pabrinex) · Vitamin B1 (Thiamine) — deficiency treatment / Wernicke's encephalopathy prevention
- Dextrose 10% IV · IV glucose solution (hypoglycaemia treatment)
- Glucose · Carbohydrate / hypoglycaemia treatment
Pathways
- Diabetic Ketoacidosis (DKA) · JBDS 2013 / Joint British Diabetes Societies; NICE NG17
- Type 2 Diabetes Management · NICE NG28 2022
- Hyperthyroidism Management · BTA / ETA 2018
- Adrenal Insufficiency · Society of Endocrinology / ESE 2016
- Pituitary Apoplexy · ENEA 2011 / Pituitary Society
- Hyperosmolar Hyperglycaemic State (HHS) · NICE; JBDS; RCP — NG18
Decision support only. Always apply local guidelines and clinical judgement.